calendar
9,170 catalysts · 9,170 approval
Week of Jan 26, 1987
4Jan 28, 1987approvalHALDOL (HALOPERIDOL DECANOATE) — FDA approvalJanssen Therapeutics
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
9,170 catalysts · 9,170 approval
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: SUN PHARM INDUSTRIES. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL
Sponsor: AIPING PHARM INC. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA BRANDED PHARM. Form: TABLET. Route: ORAL
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION
Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL
Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: ANIMA. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: MOLNLYCKE HLTH. Form: SOLUTION. Route: TOPICAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: LABORATOIRE HRA. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL
Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: RISING. Form: INJECTABLE. Route: INJECTION